Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 AUD | +12.00% | 0.00% | +3.70% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 16.16M 24.82M |
---|---|---|---|---|---|
Net income 2024 * | -4M -6.14M | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 2.9M 4.45M | Net cash position 2025 * | 2.5M 3.84M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.17% |
Latest transcript on Genetic Technologies Limited
1 day | +12.00% | ||
Current month | +16.67% | ||
1 month | +16.67% | ||
6 months | -44.00% | ||
Current year | +3.70% |
Managers | Title | Age | Since |
---|---|---|---|
Simon Morriss
CEO | Chief Executive Officer | - | 21-01-31 |
Erika Spaeth
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Jerzy Muchnicki
BRD | Director/Board Member | - | 18-01-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 14-09-23 | |
Chairman | - | 18-01-30 | |
Jerzy Muchnicki
BRD | Director/Board Member | - | 18-01-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.14 | +12.00% | 7 391 |
24-03-27 | 0.125 | -10.71% | 38,303 |
24-03-26 | 0.14 | +3.70% | 12,083 |
24-03-25 | 0.135 | 0.00% | 50,547 |
24-03-22 | 0.135 | -3.57% | 517,936 |
Delayed Quote Australian S.E., March 28, 2024 at 12:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.70% | 9.41M | |
+1.44% | 99.96B | |
+23.06% | 87.73B | |
+10.63% | 29.33B | |
-4.81% | 18.21B | |
-4.55% | 14.51B | |
+19.77% | 12.22B | |
+31.18% | 12B | |
-0.24% | 11.94B | |
-12.27% | 11.63B |